vs
Side-by-side financial comparison of Incyte (INCY) and HANOVER INSURANCE GROUP, INC. (THG). Click either name above to swap in a different company.
HANOVER INSURANCE GROUP, INC. is the larger business by last-quarter revenue ($1.7B vs $1.3B, roughly 1.3× Incyte). Incyte runs the higher net margin — 23.8% vs 11.0%, a 12.9% gap on every dollar of revenue. On growth, Incyte posted the faster year-over-year revenue change (20.9% vs 6.1%). Over the past eight quarters, Incyte's revenue compounded faster (10.4% CAGR vs 5.2%).
Incyte Corporation is an American multinational pharmaceutical company with headquarters in Wilmington, Delaware. The company currently operates manufacturing and R&D locations in North America, Europe, and Asia.
The Hanover Insurance Group, Inc. is an insurance company based in Worcester, Massachusetts. It was the original name of a property-liability insurance firm established in 1852, and it remained a publicly traded company under that name until the early 1990s, when it changed its name to Allmerica Property & Casualty Companies.
INCY vs THG — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $1.3B | $1.7B |
| Net Profit | $303.3M | $186.8M |
| Gross Margin | — | — |
| Operating Margin | 23.7% | 11.1% |
| Net Margin | 23.8% | 11.0% |
| Revenue YoY | 20.9% | 6.1% |
| Net Profit YoY | 91.7% | 45.7% |
| EPS (diluted) | $1.47 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $1.3B | $1.7B | ||
| Q4 25 | $1.5B | $1.7B | ||
| Q3 25 | $1.4B | $1.7B | ||
| Q2 25 | $1.2B | $1.7B | ||
| Q1 25 | $1.1B | $1.6B | ||
| Q4 24 | $1.2B | $1.6B | ||
| Q3 24 | $1.1B | $1.6B | ||
| Q2 24 | $1.0B | $1.5B |
| Q1 26 | $303.3M | $186.8M | ||
| Q4 25 | $299.3M | $198.5M | ||
| Q3 25 | $424.2M | $178.7M | ||
| Q2 25 | $405.0M | $157.1M | ||
| Q1 25 | $158.2M | $128.2M | ||
| Q4 24 | $201.2M | $167.9M | ||
| Q3 24 | $106.5M | $102.1M | ||
| Q2 24 | $-444.6M | $40.5M |
| Q1 26 | — | — | ||
| Q4 25 | 92.0% | — | ||
| Q3 25 | 92.8% | — | ||
| Q2 25 | 93.5% | — | ||
| Q1 25 | 93.0% | — | ||
| Q4 24 | 92.5% | — | ||
| Q3 24 | 92.4% | — | ||
| Q2 24 | 92.7% | — |
| Q1 26 | 23.7% | 11.1% | ||
| Q4 25 | 22.3% | 17.3% | ||
| Q3 25 | 32.5% | 14.9% | ||
| Q2 25 | 43.6% | 12.7% | ||
| Q1 25 | 19.5% | 11.6% | ||
| Q4 24 | 25.6% | 16.1% | ||
| Q3 24 | 12.8% | 9.6% | ||
| Q2 24 | -45.8% | 6.2% |
| Q1 26 | 23.8% | 11.0% | ||
| Q4 25 | 19.9% | 11.9% | ||
| Q3 25 | 31.1% | 10.7% | ||
| Q2 25 | 33.3% | 9.5% | ||
| Q1 25 | 15.0% | 8.0% | ||
| Q4 24 | 17.1% | 10.6% | ||
| Q3 24 | 9.4% | 6.5% | ||
| Q2 24 | -42.6% | 2.6% |
| Q1 26 | $1.47 | — | ||
| Q4 25 | $1.46 | $5.46 | ||
| Q3 25 | $2.11 | $4.90 | ||
| Q2 25 | $2.04 | $4.30 | ||
| Q1 25 | $0.80 | $3.50 | ||
| Q4 24 | $0.90 | $4.60 | ||
| Q3 24 | $0.54 | $2.80 | ||
| Q2 24 | $-2.04 | $1.12 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $243.5M |
| Total DebtLower is stronger | — | $843.8M |
| Stockholders' EquityBook value | $5.6B | $3.0B |
| Total Assets | $7.3B | $16.5B |
| Debt / EquityLower = less leverage | — | 0.28× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $243.5M | ||
| Q4 25 | $3.1B | $1.1B | ||
| Q3 25 | $2.5B | $915.7M | ||
| Q2 25 | $2.0B | $244.1M | ||
| Q1 25 | $1.9B | $315.1M | ||
| Q4 24 | $1.7B | $435.5M | ||
| Q3 24 | $1.3B | $427.1M | ||
| Q2 24 | $987.3M | $337.6M |
| Q1 26 | — | $843.8M | ||
| Q4 25 | — | $843.3M | ||
| Q3 25 | — | $843.0M | ||
| Q2 25 | — | $347.8M | ||
| Q1 25 | — | $722.5M | ||
| Q4 24 | — | $722.3M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | $5.6B | $3.0B | ||
| Q4 25 | $5.2B | $3.6B | ||
| Q3 25 | $4.7B | $3.4B | ||
| Q2 25 | $4.2B | $3.2B | ||
| Q1 25 | $3.7B | $3.0B | ||
| Q4 24 | $3.4B | $2.8B | ||
| Q3 24 | $3.2B | $2.9B | ||
| Q2 24 | $3.0B | $2.6B |
| Q1 26 | $7.3B | $16.5B | ||
| Q4 25 | $7.0B | $16.9B | ||
| Q3 25 | $6.3B | $16.8B | ||
| Q2 25 | $5.8B | $15.7B | ||
| Q1 25 | $5.7B | $15.5B | ||
| Q4 24 | $5.4B | $15.3B | ||
| Q3 24 | $5.0B | $15.4B | ||
| Q2 24 | $4.7B | $14.9B |
| Q1 26 | — | 0.28× | ||
| Q4 25 | — | 0.24× | ||
| Q3 25 | — | 0.25× | ||
| Q2 25 | — | 0.11× | ||
| Q1 25 | — | 0.24× | ||
| Q4 24 | — | 0.25× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
INCY
Segment breakdown not available.
THG
| Premiums earned | $1.6B | 92% |
| Other | $124.6M | 7% |
| Fees and other income | $6.2M | 0% |
